Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2019 Sep 5;11(9):1312.
doi: 10.3390/cancers11091312.

Neuromedin U: A Small Peptide in the Big World of Cancer

Patrycja Przygodzka  1 , Kamila Soboska  2   3 , Ewelina Sochacka  2   3 , Joanna Boncela  4
Affiliations
Review

Neuromedin U: A Small Peptide in the Big World of Cancer

Patrycja Przygodzka et al. Cancers (Basel). .

Erratum in

Abstract

Neuromedin U (NMU), a neuropeptide isolated from porcine spinal cord and named because of its activity as a rat uterus smooth muscle contraction inducer, is emerging as a new player in the tumorigenesis and/or metastasis of many types of cancers. Expressed in a variety of tissues, NMU has been shown to possess many important activities in the central nervous system as well as on the periphery. Along with the main structural and functional features of NMU and its currently known receptors, we summarized a growing number of recently published data from different tissues and cells that associate NMU activity with cancer development and progression. We ask if, based on current reports, NMU can be included as a marker of these processes and/or considered as a therapeutic target.

Keywords: GPCR receptors; NMU; Neuromedin U; cancer.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
The current paradigm of neuromedin U signalling.
Figure 2
Figure 2
NMU expression and activity is regulated at multiple cellular levels.
See this image and copyright information in PMC

References

    1. Mitchell J.D., Maguire J.J., Davenport A.P. Emerging pharmacology and physiology of neuromedin U and the structurally related peptide neuromedin S. Br. J. Pharmacol. 2009;158:87–103. doi: 10.1111/j.1476-5381.2009.00252.x. - DOI - PMC - PubMed
    1. Brighton P.J., Szekeres P.G., Willars G.B. Neuromedin U and its receptors: Structure, function, and physiological roles. Pharmacol. Rev. 2004;56:231–248. doi: 10.1124/pr.56.2.3. - DOI - PubMed
    1. Mori K., Ida T., Fudetani M., Mori M., Kaiya H., Hino J., Nakahara K., Murakami N., Miyazato M., Kangawa K. Identification of neuromedin U precursor-related peptide and its possible role in the regulation of prolactin release. Sci. Rep. 2017;7 doi: 10.1038/s41598-017-10319-9. - DOI - PMC - PubMed
    1. Mori K., Miyazato M., Ida T., Murakami N., Serino R., Ueta Y., Kojima M., Kangawa K. Identification of neuromedin S and its possible role in the mammalian circadian oscillator system. EMBO J. 2005;24:325–335. doi: 10.1038/sj.emboj.7600526. - DOI - PMC - PubMed
    1. Mori K., Miyazato M., Kangawa K. Neuromedin S: Discovery and functions. Results Probl. Cell Differ. 2008;46:201–212. doi: 10.1007/400_2007_054. - DOI - PubMed

LinkOut - more resources